Incidence and Prevalence of Children's Diffuse Lung Disease in Spain.

TitleIncidence and Prevalence of Children's Diffuse Lung Disease in Spain.
Publication TypeJournal Article
Year of Publication2022
AuthorsTorrent-Vernetta, A, Gaboli, M, Castillo-Corullón, S, Mondéjar-López, P, Santiago, VSanz, Costa-Colomer, J, Osona, B, Torres-Borrego, J, de la Serna-Blázquez, O, Alonso, SBellón, Aguilera, PCaro, de Atauri, ÁGimeno-Dí, Soria, AValenzuela, Ayats, R, de Vicente, CMartin, González, VVelasco, González, JDomingo Mo, Calderín, EMaría Can, Pastor-Vivero, MDolores, Álvarez, MÁngeles V, Rovira-Amigo, S, Serrano, IIglesias, Izquierdo, ADíez, Messa, Ide Mir, Gartner, S, Navarro, A, Baz-Redón, N, Carmona, R, Camats-Tarruella, N, Fernández-Cancio, M, Rapp, C, Dopazo, J, Griese, M, Moreno-Galdó, A
Corporate AuthorsChILD-Spain Group
JournalArch Bronconeumol
Date Published2022 Jan

BACKGROUND: Children's diffuse lung disease, also known as children's Interstitial Lung Diseases (chILD), are a heterogeneous group of rare diseases with relevant morbidity and mortality, which diagnosis and classification are very complex. Epidemiological data are scarce. The aim of this study was to analyse incidence and prevalence of chILD in Spain.METHODS: Multicentre observational prospective study in patients from 0 to 18 years of age with chILD to analyse its incidence and prevalence in Spain, based on data reported in 2018 and 2019.RESULTS: A total of 381 cases with chILD were notified from 51 paediatric pulmonology units all over Spain, covering the 91.7% of the paediatric population. The average incidence of chILD was 8.18 (CI 95% 6.28-10.48) new cases/million of children per year. The average prevalence of chILD was 46.53 (CI 95% 41.81-51.62) cases/million of children. The age group with the highest prevalence were children under 1 year of age. Different types of disorders were seen in children 2-18 years of age compared with children 0-2 years of age. Most frequent cases were: primary pulmonary interstitial glycogenosis in neonates (17/65), neuroendocrine cell hyperplasia of infancy in infants from 1 to 12 months (44/144), idiopathic pulmonary haemosiderosis in children from 1 to 5 years old (13/74), hypersensitivity pneumonitis in children from 5 to 10 years old (9/51), and scleroderma in older than 10 years old (8/47).CONCLUSIONS: We found a higher incidence and prevalence of chILD than previously described probably due to greater understanding and increased clinician awareness of these rare diseases.

Alternate JournalArch Bronconeumol
PubMed ID35249699